Verapamil Hydrochloride
Product Images NDC 0409-9633

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Verapamil Hydrochloride (NDC 0409-9633). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Verapamil Hydrochloride (Verapamil 01)

FDA Label Image

Logo (Verapamil 02)

FDA Label Image

Principal Display Panel (4 mL Vial Label)

This is a description of a medication called AmL Single-dose with the NDC code 0409-1144-62. The medication contains Verapamil HCI and is available in injection form. It should be protected from light and is for L.V. use only. Each dose contains 10 mg of the medication per 4 mL (2.5 mg/mL). The medication is distributed by Hospira, Inc. in Lake Forest, IL, in the United States. The last line contains a barcode.*

FDA Label Image

Principal Display Panel (4 mL Vial Carton)

Verapamil Hydrochloride Injection, USP is a medication that comes in a single-dose Flip-top vial. The vial information include the name of the medicine, the concentration of the drug in the injection, and the protection requirement against light during transportation and storage. The medication is made in Italy and distributed by Hospira, Inc. This drug is intended for intravenous use only and should be used by trained professionals. The text also presents dosage guidelines for Verapamil Hydrochloride Injection, USP.*

FDA Label Image

Principal Display Panel (2 mL Vial Label)

This is a description of a Verapamil HCI injection that comes in a single-dose, with 5mg/2mL, and an NDC code of 0409-1144-65. It is meant for intravenous use only and should be protected from light. The injection is distributed by Hospira, Inc., based in Lake Forest, IL 60045, USA.*

FDA Label Image

Principal Display Panel (2 mL Vial Carton)

Each mL of Verapamil Hydrochloride Inj, USP contains 2.5 mg of verapamil hydrochloride and 8.5 mg of sodium chloride, and may contain hydrochloric acid for pH adjustment. The solution is sterile and nonpyrogenic, with a pH range between 4.0 and 6.5 and an osmolality of 0.301 mOsmol/mL (calc.). It is intended for intravenous use only and should be administered slowly over a period of at least two minutes. Unused portions should be discarded. Dosage information is provided in the insert. The text also contains some unreadable characters, likely due to errors.*

FDA Label Image

Principal Display Panel (2 mL Ampul Label)

This is a description of an injectable medication called Verapamil HCI, which comes in a 5mg/2mL concentration (2.5mg/mL) and is designed for intravenous use only. The medication is packaged with a lot number and expiration date, and should be protected from light.*

FDA Label Image

Principal Display Panel (2 mL Ampul Container Label)

This is a prescription injection medication containing Verapamil Hydrochloride. It is supplied as a 2mL single-dose ampule which should be protected from light and stored at 20-25°C until use. Each ampule contains 2.5mg of Verapamil Hydrochloride and 85mg of sodium chloride. It is intended for intravenous use only and should be injected slowly over a period of at least two minutes. It is recommended to discard any unused portion. The usual dosage should be determined by a medical professional and is available in the insert. This medication is distributed by Hospira, Inc. and is manufactured in Italy.*

FDA Label Image

Principal Display Panel (4 mL Syringe Label)

Verapamil HCI injection is a medication used for intravenous use only. It comes in a single-dose syringe of 4 mL with a concentration of 10 mg/4 mL (2.5 mg/mL). The medication should be protected from light. The manufacturer is Lks Forest and the NDC number for this medication is 0409-9633-65.*

FDA Label Image

Principal Display Panel (4 mL Syringe Carton)

This text contains instructions for using a syringe with aseptic technique, including removing the luer cover and expelling air from the syringe. It also includes details about a medication, Verapamil Hydrochloride Injection, USP, with a concentration of 10 mg/4 mL (2.5 mg/mL). The product is distributed by Hospira, Inc. and made in Italy.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.